Clinical Trial Update: Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of Sanctura XR (trospium chloride) for reducing overactive bladder symptoms in women refractory to Detrol LA (tol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Detrol LA (tolterodine tartrate)
• Sanctura XR (trospium chloride)

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2013-09-26